QUESTCOR PHARMACEUTICALS INC's ticker is QCOR and the CUSIP is 74835Y101. A total of 324 filers reported holding QUESTCOR PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2014 | $16,856,000 | +41.4% | 182,267 | -0.7% | 0.01% | +33.3% |
Q1 2014 | $11,920,000 | -14.4% | 183,620 | -28.2% | 0.01% | -18.2% |
Q4 2013 | $13,930,000 | -5.8% | 255,829 | +0.3% | 0.01% | -15.4% |
Q3 2013 | $14,792,000 | +28.1% | 255,070 | +0.4% | 0.01% | +18.2% |
Q2 2013 | $11,550,000 | – | 254,046 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 2,251,660 | $146,200,000 | 28.53% |
Palo Alto Investors LP | 1,938,990 | $125,898,000 | 5.20% |
Valiant Capital Management, L.P. | 599,100 | $38,900,000 | 4.77% |
Espalier Global Management LLC | 1,284,800 | $83,422,000 | 4.66% |
CAPITAL MANAGEMENT CORP /VA | 178,365 | $11,581,000 | 3.95% |
Freestone Capital Holdings, LLC | 303,127 | $19,682,000 | 3.49% |
RIVULET CAPITAL, LLC | 58,000 | $3,766,000 | 3.41% |
Formidable Asset Management, LLC | 52,640 | $4,161,000 | 2.91% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,039,865 | $67,518,000 | 2.76% |
GROESBECK INVESTMENT MANAGEMENT CORP /NJ/ | 89,561 | $5,815,000 | 2.62% |